Xbrane Biopharma AB (7XB.F) Q1 2026 Earnings

20FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.14
0.33
0.79
1.25

Details

Expected EPS
-0.13588223817
Actual EPS
N/A
Surprise EPS
0.14
Surprise Percent
+100%

Description

Xbrane Biopharma AB (7XB.F) will report earnings of for Q1 2026 on February 20, 2026.

0 Comments

Share your thoughts